These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33068330)

  • 1. Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk.
    Cao D; Meng Y; Li S; Xin J; Ben S; Cheng Y; Wang M; Hua L; Cheng G
    Cancer Med; 2020 Dec; 9(24):9462-9470. PubMed ID: 33068330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer.
    Cheng Y; Meng Y; Li S; Cao D; Ben S; Qin C; Hua L; Cheng G
    Gene; 2021 Mar; 774():145432. PubMed ID: 33444688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
    Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
    Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic variants in autophagy-lysosome pathway genes with susceptibility and survival to prostate cancer.
    Zhu Q; Meng Y; Li S; Xin J; Du M; Wang M; Cheng G
    Gene; 2022 Jan; 808():145953. PubMed ID: 34500048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
    Liu X; Qian D; Liu H; Abbruzzese JL; Luo S; Walsh KM; Wei Q
    Mol Carcinog; 2020 Aug; 59(8):930-939. PubMed ID: 32367578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.
    Brunner C; Davies NM; Martin RM; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles G; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Donovan J; Hamdy FC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Zuccolo L
    Int J Cancer; 2017 Jan; 140(1):75-85. PubMed ID: 27643404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
    Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
    Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
    Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
    Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of genetic variants in estrogen metabolic pathway genes and colorectal cancer risk and survival.
    Li S; Xie L; Du M; Xu K; Zhu L; Chu H; Chen J; Wang M; Zhang Z; Gu D
    Arch Toxicol; 2018 Jun; 92(6):1991-1999. PubMed ID: 29766219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
    Zhang P; Tillmans LS; Thibodeau SN; Wang L
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
    Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
    Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.
    DeRycke MS; Larson MC; Nair AA; McDonnell SK; French AJ; Tillmans LS; Riska SM; Baheti S; Fogarty ZC; Larson NB; O'Brien DR; Cheville JC; Wang L; Schaid DJ; Thibodeau SN
    PLoS One; 2019; 14(4):e0214588. PubMed ID: 30958860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.
    Zhang Y; Zhang L; Li R; Chang DW; Ye Y; Minna JD; Roth JA; Han B; Wu X
    Ann Oncol; 2017 Jul; 28(7):1625-1630. PubMed ID: 28383694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico pathway analysis and tissue specific cis-eQTL for colorectal cancer GWAS risk variants.
    Loo LWM; Lemire M; Le Marchand L
    BMC Genomics; 2017 May; 18(1):381. PubMed ID: 28506205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants.
    Wu L; Wang J; Cai Q; Cavazos TB; Emami NC; Long J; Shu XO; Lu Y; Guo X; Bauer JA; Pasaniuc B; Penney KL; Freedman ML; Kote-Jarai Z; Witte JS; Haiman CA; Eeles RA; Zheng W;
    Cancer Res; 2019 Jul; 79(13):3192-3204. PubMed ID: 31101764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set.
    Thibodeau SN; French AJ; McDonnell SK; Cheville J; Middha S; Tillmans L; Riska S; Baheti S; Larson MC; Fogarty Z; Zhang Y; Larson N; Nair A; O'Brien D; Wang L; Schaid DJ
    Nat Commun; 2015 Nov; 6():8653. PubMed ID: 26611117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
    Rebollido-Rios R; Venton G; Sánchez-Redondo S; Iglesias I Felip C; Fournet G; González E; Romero Fernández W; Borroto Escuela DO; Di Stefano B; Penarroche-Díaz R; Martin G; Ceylan I; Costello R; Perez-Alea M
    Oncogene; 2020 Mar; 39(13):2756-2771. PubMed ID: 32015486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.
    Winter JM; Curry NL; Gildea DM; Williams KA; Lee M; Hu Y; Crawford NPS
    BMC Genomics; 2018 Jun; 19(1):450. PubMed ID: 29890952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.